Aspect Biosystems vs cellvie
Aspect Biosystems
Developing Bioprinted Tissue Therapeutics to transform how we treat some of the most elusive diseases
150 employees · est. 2013 · Canada
Aspect Biosystems is the older company (2013 vs 2018); Aspect Biosystems is the larger of the two.
Side-by-Side Comparison
| Metric | Aspect Biosystems | cellvie |
|---|---|---|
| Founded | ||
| Founded | 2013 older | 2018 |
| Headquarters | ||
| Headquarters | Canada | Switzerland |
| Employees | ||
| Employees | 150 larger | 11 |
| Industry | ||
| Industry | Biotechnology, Life Sciences | Biotechnology, Health and Wellness, Life Sciences |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Seed |
| Total Funding | ||
| Total Funding | $323.73M | $10.50M |
| Funding Rounds | ||
| Funding Rounds | 15 | 2 |
| Services | ||
| Services | Development of Bioprinted Tissue Therapeutics, Regenerative Medicine Solutions, Cutting-edge Biotech Collaborations | Mitochondrial Augmentation, Cellular Energy Recovery, Medical Research and Development, Ischemia-Reperfusion Treatment |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers focused on Metabolic and Endocrine Conditions, Research Institutions seeking advanced tissue therapies | Healthcare Providers, Organ Transplant Centers, Patients with Ischemia-Reperfusion Conditions, Aging Population with Degenerative Conditions |
| Taxonomy | ||
| Taxonomy | Bioprinted Tissue TherapeuticsCellular MedicinesRegenerative MedicineAI-Powered BioprintingHypoimmune Cell EngineeringAdvanced Biomaterials +9 | Therapeutic Mitochondria TransplantationMitochondria AugmentationMitochondria ReplacementCell-Derived MedicinesIschemia-Reperfusion InjurySolid Organ Transplantation +8 |
| Website | ||
| Website | aspectbiosystems.com | cellvie.bio |
About Aspect Biosystems
Aspect Biosystems is a pioneering force in the biotechnology landscape, focusing on bioprinted tissue therapeutics that promise to transform treatments for particularly elusive diseases. Their full-stack tissue therapeutic platform leverages proprietary AI-powered bioprinting technology, therapeutic...
About cellvie
cellvie, founded in 2018, is at the forefront of an innovative healthcare approach known as Therapeutic Mitochondria Transplantation (TMT), aiming to harness the potential of mitochondria for medical treatments. Originating from research developed by Dr. James McCully at Harvard Medical School, this...
Also comparing in this category
Comparing more than these two?
Get Aspect Biosystems, cellvie and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Aspect Biosystems compare?
A PDF of Aspect Biosystems and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Aspect Biosystems with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Aspect Biosystems on 15 Jun 2026, and cellvie on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.